2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13
±³À°ÀÏÀÚ : 2024-07-13
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü
±³À°ÁÖÁ¦ : 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : À¯ÁöÀÎ
¿¬¶ôó : 02-714-9072
À̸ÞÀÏ : diabetes@kams.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í »çÀüµî·Ï 1¸¸¿ø, ÇöÀåµî·Ï 2¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:05~13:25 eGFR trajectory ±è»ó¼ö (ºÎ»êÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:25~13:45 Novel risk prediction equation for cardio- kidney-metabolic health Á¤ÀÎÇÏ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:45~14:05 New biomarkers for prediction of DKD ±è¹Ì°æ(°è¸íÀÇ´ë)
Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:05~14:20 ÆгÎÅäÀÇ ±èÈ¿Á¤(À»ÁöÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:20~14:40 DKD and MASLD crosstalk in T2D ¹èÀçÇö(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:40~15:00 Cardiorenal Nexus in Diabetes À̽ÂÀº(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:00~15:20 Gut microbiome- DKD ¼´ÙÇý(ÀÎÇÏÀÇ´ë)
Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:20~15:35 ÆгÎÅäÀÇ ±è¼ö°æ(°æ»óÀÇ´ë)
ÈÞ½Ä 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:35~16:00 Coffee Break ()
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:00~16:20 Nutritional interventions of diabetic kidney disease Â÷ÁøÁÖ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:20~16:40 Update clinical trials of SGLT2i, GLPT-1 RA °í°üÇ¥(Á¦ÁÖÀÇ´ë )
±³À°½Ã°£ 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:40~17:00 Finerenone for the management of diabetic kidney disease ±èµ¿¸²(°Ç±¹ÀÇ´ë)
Åä·Ð 07¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 17:00~17:15 ÆгÎÅäÀÇ ±è³²ÈÆ(°í·ÁÀÇ´ë)